Ovid Therapeutics

About Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused on developing impactful medicines for rare neurological disorders such as Angelman syndrome, Fragile X syndrome, and CDKL5 deficiency disorder. The company operates in the healthcare and biotechnology market, primarily serving patients with limited or no treatment options. Ovid Therapeutics employs a science-driven and patient-focused approach, leveraging its deep understanding of human genetics and cellular function to translate discoveries into meaningful therapies. The business model revolves around research and development of novel treatments, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the commercialization of these therapies, partnerships, and potential licensing agreements. Ovid Therapeutics collaborates closely with rare neurological condition communities to provide hope and improve the quality of life for affected individuals.